Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan M Granoff

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Clinical and Vaccine Immunology : CVI|October 2, 2015
Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C VaccineRaffaella Rossi, Peter T Beernink, Serena Giuntini, et al.
Human Vaccines|June 22, 2007
Group A antibody persistence five years after meningococcal polysaccharide vaccination in the SudanBecca A Flitter, Adil Ismail, David Vu, et al.
The Journal of Infectious Diseases|April 19, 2008
Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigenJo Anne Welsch, Sanjay Ram, Oliver Koeberling, et al.
Clinical and Vaccine Immunology : CVI|June 4, 2010
Impaired immunogenicity of a meningococcal factor H-binding protein vaccine engineered to eliminate factor h bindingPeter T Beernink, Jutamas Shaughnessy, Sanjay Ram, et al.
Lancet (London, England)|May 4, 2002
Development of vaccines against meningococcal diseaseLuis Jódar, Ian M Feavers, David Salisbury, et al.
Infection and Immunity|December 24, 2002
Age-related disparity in functional activities of human group C serum anticapsular antibodies elicited by meningococcal polysaccharide vaccineShannon L Harris, W James King, Wendy Ferris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 6, 2017
Serum Bactericidal Antibody Responses of Students Immunized With a Meningococcal Serogroup B Vaccine in Response to an Outbreak on a University CampusEduardo Lujan, Kathleen Winter, Jillandra Rovaris, et al.
Clinical and Vaccine Immunology : CVI|June 2, 2017
Breadth and Duration of Meningococcal Serum Bactericidal Activity in Health Care Workers and Microbiologists Immunized with the MenB-FHbp VaccineEduardo Lujan, Elizabeth Partridge, Serena Giuntini, et al.
The Journal of Infectious Diseases|July 20, 2005
Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870Victor C Hou, Oliver Koeberling, Jo Anne Welsch, et al.
Infection and Immunity|November 3, 2010
Effect of factor H-binding protein sequence variation on factor H binding and survival of Neisseria meningitidis in human bloodKathleen Y Dunphy, Peter T Beernink, Barbara Brogioni, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Clinical and Vaccine Immunology : CVI|October 2, 2015
Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C VaccineRaffaella Rossi, Peter T Beernink, Serena Giuntini, et al.
Human Vaccines|June 22, 2007
Group A antibody persistence five years after meningococcal polysaccharide vaccination in the SudanBecca A Flitter, Adil Ismail, David Vu, et al.
The Journal of Infectious Diseases|April 19, 2008
Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigenJo Anne Welsch, Sanjay Ram, Oliver Koeberling, et al.
Clinical and Vaccine Immunology : CVI|June 4, 2010
Impaired immunogenicity of a meningococcal factor H-binding protein vaccine engineered to eliminate factor h bindingPeter T Beernink, Jutamas Shaughnessy, Sanjay Ram, et al.
Lancet (London, England)|May 4, 2002
Development of vaccines against meningococcal diseaseLuis Jódar, Ian M Feavers, David Salisbury, et al.
Infection and Immunity|December 24, 2002
Age-related disparity in functional activities of human group C serum anticapsular antibodies elicited by meningococcal polysaccharide vaccineShannon L Harris, W James King, Wendy Ferris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 6, 2017
Serum Bactericidal Antibody Responses of Students Immunized With a Meningococcal Serogroup B Vaccine in Response to an Outbreak on a University CampusEduardo Lujan, Kathleen Winter, Jillandra Rovaris, et al.
Clinical and Vaccine Immunology : CVI|June 2, 2017
Breadth and Duration of Meningococcal Serum Bactericidal Activity in Health Care Workers and Microbiologists Immunized with the MenB-FHbp VaccineEduardo Lujan, Elizabeth Partridge, Serena Giuntini, et al.
The Journal of Infectious Diseases|July 20, 2005
Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870Victor C Hou, Oliver Koeberling, Jo Anne Welsch, et al.
Infection and Immunity|November 3, 2010
Effect of factor H-binding protein sequence variation on factor H binding and survival of Neisseria meningitidis in human bloodKathleen Y Dunphy, Peter T Beernink, Barbara Brogioni, et al.
Pageof 10